Senores Pharmaceuticals Limited
Aditya Birla Sun Life Insurance decreased its stake in Senores Pharmaceuticals from 1.62% to 1.28%, selling 1,56,984 shares.
A pharmaceutical manufacturer that produces complex generic medicines certified by global regulatory authorities including the FDA and WHO. Incorporated in 2015, the company focuses on developing and supplying affordable, high-quality pharmaceutical formulations to domestic and international markets. Its operations center on manufacturing specialized generics that address critical therapeutic areas while maintaining stringent international quality standards and compliance requirements.
Joint venture between Aditya Birla Capital and Sun Life Financial of Canada. Total AUM of Rs 99,496 crore as of March 2025. CIO Devendra Singhvi runs a diversified equity book across ULIP, participating and group funds with a multi-cap bias. Active in primary issuances and secondary market block deals across sectors.